Marijuana Business Magazine July 2019

Marijuana Business Magazine | July 2019 26 Industry Asks FDA for Guidance on CBD At a landmark cannabis review by the U.S. Food and Drug Administration (FDA), CBD manufacturers joined with academics, consumer packaged goods manufacturers and agriculture officials to ask a panel of regulators for a uniform set of guidelines for producing, packaging and labeling cannabis extracts. The FDA review was the result of hemp no longer being a controlled substance, leading to countless new hemp-derived products being sold in stores and online. Dr. Ned Sharpless, acting head of the FDA, made clear that dosing is going to be a key factor in the FDA’s approach to cannabis-derived products in food, drugs and cosmetics. “While we have seen an explosion of products contain- ing CBD, there is still much that we don’t know about them,” Sharpless said. “How much CBD is safe for a consumer per day? How much is too much?” Sharpless gave no indication how long it would take the FDA to answer dosing questions or to establish any other rules that would bring a national standard to the CBD industry. Canada’s first nursery license marks ‘key point’ in cannabis industry’s development Canada’s cannabis regulatory agency issued its first nursery license to Alberta-based InPlanta Biotechnol- ogy—a milestone that could lead to a more diversified selection of marijuana from a wider variety of genetics and a more competitive legal market. (Turn to page 10 to read a Q&A with InPlanta Biotechnology co-founder Darryl Hudson.) Industry Developments | International & United States Countries included have passed legislation at the federal level and must fulfill at least one of the following criteria: • Cultivation or manufacture of medical cannabis allowed. • Doctors can prescribe medical cannabis. • Import and/or export of medical cannabis allowed. High: Countries at the forefront of the global industry. Frameworks are established, and adoption is well underway. Medium: Implementation has begun but is still limited or restricted; lots of room for the market to develop. Low: Legislation has been passed, but implementation is very limited or nonexistent. Decriminalization is not included. MAP LEGEND High level of medical development/implementation Medium level of medical development/implementation Low level of medical development/implementation Other - federally illegal but unique circumstances Recreational National & International News